GENNEX LABORATORIES
Back to Income Statement
|
GENNEX LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹11 Cr | ₹6.19 Cr | ₹4.11 Cr | ₹4.04 Cr | ₹1.86 Cr |
What is the latest Consolidated Net Profit of GENNEX LABORATORIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹6.19 Cr |
Mar2022 | ₹4.11 Cr |
Mar2021 | ₹4.04 Cr |
Mar2020 | ₹1.86 Cr |
How is Consolidated Net Profit of GENNEX LABORATORIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | 83.61 | |
Mar2023 | ₹6.19 Cr | 50.89 | |
Mar2022 | ₹4.11 Cr | 1.66 | |
Mar2021 | ₹4.04 Cr | 117.56 | |
Mar2020 | ₹1.86 Cr | - |
Compare Consolidated Net Profit of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹291.0 Cr | 0.8% | 2.8% | -52.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹392,567.0 Cr | 0.5% | 4.6% | -18.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹151,601.0 Cr | -3.2% | -6.7% | 4.4% | Stock Analytics | |
CIPLA | ₹122,284.0 Cr | 0.3% | -3.5% | -10.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,593.0 Cr | 0.9% | -0.6% | 3.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,014.0 Cr | -2.2% | -0.9% | -9.4% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | 0.8% |
2.8% |
-52.7% |
SENSEX | -0.9% |
0.8% |
-5.7% |
You may also like the below Video Courses